Biotech grants in South Korea

Between cycles

Funds Korean bio industrial ecosystems by supporting ecosystem development and collaboration.

Between cycles

Funds Korean industry organizations that support EEN membership and cross-border business networks.

Between cycles

Funds Korean-French teams developing industrial technologies through bilateral cooperation and joint projects.

Between cycles

Supports early-stage Korean-Israeli industrial research through feasibility studies that test joint collaboration potential.

Between cycles

Supports Korea's industrial technology development through ministry-backed research opportunities across key sectors.

Between cycles

Supports scaling Korean startups with grants and resources for rapid commercialization and business expansion.

Between cycles

Offers Korean technology ventures matching support for execution and commercialization readiness.

Closed

Supports early Korean startup teams through a competitive challenge route for commercialization and market entry readiness.

Closed

Offers foreign-founded startups a flagship pathway to enter Korea with acceleration, mentoring, and growth-focused market support.

Closed

Funds Korean company consortia building international joint innovation in advanced technology fields.

Closed

Supports would-be entrepreneurs in Korea with commercialization guidance and early innovation funding before formal company launch.

Open

Funds a €15M project that turns microbiome signals into a test for spotting cancer risk years ahead of any symptoms.

Open

Funds a €5M programme that pairs EU and Associated Country research institutions with Ukrainian cancer centres for joint training and staff exchanges.

Open

Funds up to four €8-9M grants for teams building AI-driven digital models of a patient's cancer to predict how it develops and guide personalised treatment.

Open

Funds three pragmatic clinical trials, €7-8M each, testing existing cancer immunotherapies in real-world care for patients whose disease resists treatment.

Open

Funds rare-disease research calls, clinical trial networks and shared data for ERDERA's second phase — open only to the existing coordinator.

Open

Funds one consortium to build a certified micro-credentials programme teaching entrepreneurship and innovation to health and life-science students.

Open

Funds €9M research consortia that map, monitor and identify deep-sea species and habitats to guide EU and global ocean protection targets.

Open

Funds €5M lump-sum projects that build sensor and lab-based methods to map, test and protect Europe's groundwater ecosystems.

Open

Funds two €4M projects for European consortia building bio-based products and studying whether people will actually adopt them.

Open

Funds research consortia developing the pre-normative science behind future standards for bio-based chemicals, polymers and other bio-based products.

Open

Funds three €4M lump-sum grants for industrial and environmental biotech — synthetic biology, gene editing, biofoundries — not health biotech or biofuels.

Open

Funds two €5M projects turning marine organisms — algae, fungi, invertebrates — into safer bio-based replacements for adhesives, coatings and chemicals.

Open

Funds consortia developing biotech and nature-based decontamination methods for war-damaged land, water and air, proven on real sites in Ukraine.